President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to manage this advanced prostate cancer.

A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...

A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...

Study findings further strengthen pivotal role of PSMA PET in the management of men with recurrence of prostate cancer after ...

PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...

June is men's health month. You've probably been reminded to 'get your PSA checked.' but you may not have heard of a PSMA scan. June is men's health month. You've probably been reminded to 'get your ...

PORTLAND, Ore. (KOIN) – June is men’s health month. You’ve probably been reminded to ‘get your PSA checked.’ but you may not have heard of a PSMA scan. Found in 80% of prostate cancers, PSMA is a ...

The PRIMARY2 phase 3 trial found that PSMA PET-CT in men with normal or equivocal MRI results safely halved the number of prostate biopsies, maintained non-inferior detection of clinically significant ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Short-course enzalutamide in recurrent prostate cancer slashes PSA, but PSMA-PET tumor volume misleads, raising overtreatment concerns. This interview with Ravi Madan, MD, acting deputy chief of the ...

Host Dr. Davide Soldato and guests Dr. David Einstein and Dr. Ravi Madan discuss JCO article, "National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial ...